Treatment outcomes for hepatoblastoma: An institution's experience over two decades

Pediatric Surgery International

Volumn 23, Issue 2, 2007, Pages 103-109

  Ang, J P ^a   Heath, J A ^a   Donath, S ^a   Khurana, S ^a   Auldist, A ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Hepatoblastoma; Liver resection; Outcome; Survival; Treatment

Indexed keywords

ALPHA FETOPROTEIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; VINCRISTINE;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEPATOBLASTOMA; HUMAN; INFANT; INFERIOR CAVA VEIN; MALE; PARTIAL HEPATECTOMY; PATHOLOGY; PRIORITY JOURNAL; RADIOLOGY; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATOBLASTOMA; HUMANS; INFANT; LIVER NEOPLASMS; MALE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33846588427     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-006-1834-1     Document Type: Article

References (37)

1. Raney B (1997) Hepatoblastoma in children: a review. J Pediatr Hematol Oncol 19(5):418-422
2. Perilongo G, Shafford E, Plaschkes J (2000) SIOPEL trials using preoperative chemotherapy in hepatoblastoma. Lancet Oncol 1:94-100
3. Schnater JM, Kohler SE, Lamers WH, von Schweinitz D, Aronson DC (2003) Where do we stand with hepatoblastoma? A review. Cancer 98(4):668-678
4. Ansell P, Mitchell CD, Roman E, Simpson J, Birch JM, Eden TOB (2005) Relationships between perinatal and maternal characteristics and hepatoblastoma: a report from the UKCCS. Eur J Cancer 41(5):741-748
5. Feusner J, Plaschkes J (2002) Hepatoblastoma and low birth weight: a trend or chance observation? Med Pediatr Oncol 39(5):508-509
6. Ikeda H, Hachitanda Y, Tanimura M, Maruyama K, Koizumi T, Tsuchida Y (1998) Development of unfavorable hepatoblastoma in children of very low birth weight: results of a surgical and pathologic review. Cancer 82(9):1789-1796
7. Ikeda H, Matsuyama S, Tanimura M (1997) Association between hepatoblastoma and very low birth weight: a trend or a chance? J Pediatr 130(4):557-560
8. Kapfer SA, Petruzzi MJ, Caty MG (2004) Hepatoblastoma in low birth weight infants: an institutional review. Pediatr Surg Int 20(10):753-756
9. Maruyama K, Ikeda H, Koizumi T, Tsuchida Y (1999) Prenatal and postnatal histories of very low birthweight infants who developed hepatoblastoma. Pediatr Int 41(1):82-89
10. Maruyama K, Ikeda H, Koizumi T, Tsuchida Y, Tanimura M, Nishida H, Takahashi N, Fujimura M, Tokunaga Y (2000) Case-control study of perinatal factors and hepatoblastoma in children with an extremely low birthweight. Pediatr Int 42(5):492-498
11. Oue T, Kubota A, Okuyama H, Kawahara H, Nara K, Kawa K, Kitajima H (2003) Hepatoblastoma in children of extremely low birth weight: a report from a single perinatal center. J Pediatr Surg 38(1):134-137
12. Brown J, Perilongo G, Shafford E, Keeling J, Pritchard J, Brock P, Dicks-Mireaux C, Phillips A, Vos A, Plaschkes J (2000) Pretreatment prognostic factors for children with hepatoblastoma - results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 36(11):1418-1425
13. Douglass EC, Reynolds M, Finegold M, Cantor AB, Glicksman A (1993) Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study. J Clin Oncol 11(1):96-99
14. Ehrlich PF, Greenberg ML, Filler RM (1997) Improved long-term survival with preoperative chemotherapy for hepatoblastoma. J Pediatr Surg 32(7):999-1003
15. Fuchs J, Bode U, von Schweinitz D, Weinel P, Erttmann R, Harms D, Mildenberger H (1999) Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94. Klin Padiatr 211(4):305-309
16. Fuchs J, Rydzynski J, Von Schweinitz D, Bode U, Hecker H, Weinel P, Burger D, Harms D, Erttmann R, Oldhafer K, Mildenberger H (2002) Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 95(1):172-182
17. Ortega JA, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Finegold MJ, Haas JE, King DR, Liu-Mares W, Sensel MG, Krailo MD (2000) Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 18(14):2665-2775
18. Perilongo G, Brown J, Shafford E, Brock P, De Camargo B, Keeling JW, Vos A, Philips A, Pritchard J, Plaschkes J (2000) Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors. Cancer 89(8):1845-1853
19. Perilongo G, Shafford E, Maibach R, Aronson D, Brugieres L, Brock P, Childs M, Czauderna P, MacKinlay G, Otte JB, Pritchard J, Rondelli R, Scopinaro M, Staalman C, Plaschkes J (2004) Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Paediatric Oncology - SIOPEL 2. Eur J Cancer 40(3):411-421
20. Stringer MD, Hennayake S, Howard ER, Spitz L, Shafford EA, Mieli-Vergani G, Saxena R, Malone M, Dicks-Mireaux C, Karani J (1995) Improved outcome for children with hepatoblastoma. Br J Surg 82(3):386-391
21. Suita S, Tajiri T, Takamatsu H, Mizote H, Nagasaki A, Inomata Y, Hara T, Okamura J, Miyazaki S, Kawakami K, Eguchi H, Tsuneyoshi M (2004) Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen - a report from the study group for pediatric solid malignant tumors in the Kyushu area. J Pediatr Surg 39(2):195-198
22. von Schweinitz D (2000) Identification of risk groups in hepatoblastoma - another step in optimising therapy. Eur J Cancer 36(11):1343-1346
23. von Schweinitz D, Byrd DJ, Hecker H, Weinel P, Bode U, Burger D, Erttmann R, Harms D, Mildenberger H (1997) Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Eur J Cancer 33(8):1243-1249
24. Brugieres L, Plaschkes J, MacKinlay G, Cecchetto P, Czauderna P, Aronson D, Zimmerman A, Perilongo G (2000) Hepatoblastoma - microscopical residual disease (MRD) after delayed surgery; prognostic implications. Med Pediatr Oncol 35(3):177
25. Towu E, Kiely E, Pierro A, Spitz L (2004) Outcome and complications after resection of hepatoblastoma. J Pediatr Surg 39(2):199-202
26. Dicken BJ, Bigam DL, Lees GM (2004) Association between surgical margins and long-term outcome in advanced hepatoblastoma. J Pediatr Surg 39(5):721-725
27. Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte J-B, Brugieres L, Czauderna P, MacKinlay G, Vos A (2002) Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 94(4):1111-1120
28. Otte JB, de Ville de Goyet J, Reding R (2005) Liver transplantation for hepatoblastoma: indications and contraindications in the modern era. Pediatr Transplant 9(5):557-565
29. Otte JB, Pritchard J, Aronson DC, Brown J, Czauderna P, Maibach R, Perilongo G, Shafford E, Plaschkes J (2004) Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 42(1):74-83
30. Czauderna P, Otte JB, Aronson DC, Gauthier F, Mackinlay G, Roebuck D, Plaschkes J, Perilongo G (2005) Guidelines for surgical treatment of hepatoblastoma in the modern era - recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer 41(7):1031-1036
31. Austin MT, Leys CM, Feurer ID, Lovvorn HN III, O'Neill JA Jr, Pinson CW, Pietsch JB (2006) Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database. J Pediatr Surg 41(1):182-186
32. Tiao GM, Bobey N, Allen S, Nieves N, Alonso M, Bucuvalas J, Wells R, Ryckman F (2005) The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation. J Pediatr 146(2):204-211
33. Ortega JA, Krailo MD, Haas JE, King DR, Ablin AR, Quinn JJ, Feusner J, Campbell JR, Lloyd DA, Cherlow J (1991) Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group. J Clin Oncol 9(12):2167-2176
34. Van Tornout JM, Buckley JD, Quinn JJ, Feusner JH, Krailo MD, King DR, Hammond GD, Ortega JA (1997) Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group. J Clin Oncol 15(3):1190-1197
35. von Schweinitz D, Hecker H, Harms D, Bode U, Weinel P, Burger D, Erttmann R, Mildenberger H (1995) Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma - a report from the German Cooperative Pediatric Liver Tumor Study HB-89. J Pediatr Surg 30(6):845-852
36. Reynolds P, Urayama KY, Von Behren J, Feusner J (2004) Birth characteristics and hepatoblastoma risk in young children. Cancer 100(5):1070-1076
37. Ross JA, Gurney JG (1998) Hepatoblastoma incidence in the United States from 1973 to 1992. Med Pediatr Oncol 30(3):141-142